As part of our ongoing commitment to environmental stewardship and industry leadership in sustainable clinical research, ...

Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...

The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva Pharma , to help ...

The global Suppositories Market, valued at US$1.56 billion in 2024 stood at US$1.63 billion in 2025 and is projected to ...

The biopharmaceutical industry is growing rapidly as a result of significant advancements in biotechnology and drug ...

Teva Pharmaceutical Industries Ltd. agreed to end its lawsuit alleging Amneal Pharmaceuticals of New York LLC and its affiliates infringed patents for the pharmaceutical giant’s asthma inhaler. Judge ...

Teva Pharmaceutical Industries reported a better than expected increase in second-quarter profit on Wednesday, helped by a 26 ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in antiemetic therapies, personalized medicine, and digital health technologies.

Teva pharmaceuticals has issued a voluntary recall of one lot of its reflux medication after discovering that bottles contained tablets of a drug used to treat fluid retention. The recall affects ...

Minocycline hydrochloride capsule: Teva Pharmaceuticals has discontinued the 75 mg capsule presentation of minocycline hydrochloride, an antibiotic used for bacterial infections, for business reasons.